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ABSTRACT
The developing nervous system consists of a small number of multipotent precursors that
undergo extensive proliferation to generate the neurons and glia that make up the adult brain.
Elucidating the mechanisms that control the growth and differentiation of these cells is important not
only for understanding normal neural development but also for understanding the etiology of central
nervous system tumors. A particularly striking example of this is in the cerebellum. Recent studies
have suggested that the Sonic hedgehog-Patched signaling pathway plays a critical role in regulating
the proliferation of cerebellar granule cell precursors and is also a major target of mutation in the
cerebellar tumor medulloblastoma. In light of these observations, identiﬁcation of additional genes
that control cerebellar growth and differentiation is likely to provide important insight into the basis
of cerebellar tumors. Similarly, analysis of gene expression in medulloblastoma will no doubt shed
light on previously unknown signaling pathways that regulate normal cerebellar development. The
advent of high-throughput gene expression analysis techniques — such as adapter-tagged competitive
polymerase chain reaction (ATAC-PCR), serial analysis of gene expression (SAGE), and DNA
microarrays — makes identiﬁcation of such genes faster and easier than ever before. This review
summarizes recent studies of gene expression in the cerebellum and discusses the value of such
approaches for understanding development and tumorigenesis in this tissue.
I. Development of Cerebellar Granule Cells
The cerebellum is required for motor coordination and has been implicated
in a variety of cognitive and affective functions as well (Leiner et al., 1993;
Altman and Bayer, 1997). These functions depend on precise interactions among
at least ﬁve types of neurons (Altman and Bayer, 1997). The most abundant of
these are the Purkinje cells, which carry signals from the cerebellum to other
parts of the brain, and the granule cells, which regulate the activity of Purkinje
cells. The murine cerebellum contains about 10
8 granule cells, more than the total
number of neurons in the rest of the brain. The critical importance of these cells
is evident from mutant mice, in which loss of granule cells leads to severe ataxia
(Mullen et al., 1997), and from patients with congenital granule cell degenera-
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function (Pascual-Castroviejo et al., 1994).
Granule cell development has a number of unique features that distinguish it
from other kinds of neurogenesis (Hatten and Heintz, 1995; Altman and Bayer,
1997). Whereas most neurons are born around the ventricles and then migrate
outward toward the surface of the brain, granule cells are generated on the
outside of the cerebellum and migrate inward (Figure 1). Granule cell precursors
(GCPs) initially arise from a dorsal hindbrain structure called the rhombic lip
(Alder et al., 1996; Alcantara et al., 2000; Wingate, 2001). During embryonic
life, these cells leave the rhombic lip and stream across the outer surface of the
cerebellum to form a region called the external germinal layer (EGL). After birth,
cells in the EGL undergo extensive proliferation to generate a large pool of GCPs
(Fujita et al., 1966; Mares et al., 1970). As new GCPs are generated, older cells
move inward, then exit the cell cycle and differentiate (Fishell and Hatten, 1991;
Komuro and Rakic, 1998). The differentiating cells extend axons that form
synapses with Purkinje cells, then continue to migrate inward past the Purkinje
cell bodies to their ﬁnal destination, the internal granule layer (IGL). The waves
of GCP proliferation and differentiation continue until about 3 weeks of age, at
which time the EGL disappears and all GCPs complete their migration and
differentiation into mature granule cells (Nicholson and Altman, 1972).
FIG. 1. Granule cell development. Granule cells are generated in the external germinal layer
(EGL). After birth (P0), they proliferate to generate a large pool of precursors (white circles,
P0–P14). These cells move inward, exit the cell cycle, and differentiate (gray circles). They extend
axons that synapse with Purkinje cells (gray ovals). Finally, cells migrate through the molecular layer
(ML) and Purkinje cell layer (PL) to the internal granule layer (IGL). By adulthood, all precursors
have become mature granule cells (black circles) and no EGL remains.
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The observation that mutations in the Sonic hedgehog (Shh) signaling
pathway result in cerebellar tumors in both mice and humans (Johnson et al.,
1996; Goodrich et al., 1997; Raffel et al., 1997) suggested that this pathway
might play a role in normal cerebellar growth and differentiation. Our own
studies (Wechsler-Reya and Scott, 1999) and others (Dahmane and Ruiz-i-
Altaba, 1999; Wallace, 1999) demonstrated that Purkinje cells make Shh and that
developing GCPs express all of the elements of the signaling pathway necessary
to respond to it. Addition of recombinant Shh protein to GCPs in culture induces
a 75- to 100-fold increase in thymidine incorporation within 3 days. Treatment
of cerebellar slice cultures with Shh also causes a dramatic proliferative response
and inhibits granule cell differentiation and migration. Finally, intracranial
injection of Shh-blocking antibodies during early postnatal development leads to
decreased proliferation of GCPs and a signiﬁcant reduction in the thickness of the
EGL. Together, these studies suggest that Shh is a critical regulator of GCP
proliferation.
A number of factors present in the outer EGL enhance Shh-induced prolif-
eration of GCPs. One of these is the extracellular matrix molecule, laminin
(Wechsler-Reya and Scott, 1999; Pons et al., 2001). GCPs cultured on laminin
show a 1.5- to 2-fold increase in Shh-induced proliferation, compared to cells
cultured on other substrates. The chemokine stromal cell-derived factor-1 alpha
(SDF-1), produced by the pia mater that surrounds the EGL, induces GCP
chemotaxis and also can synergize with Shh to enhance GCP proliferation in
culture (Klein et al., 2001). Finally, heparan sulfate proteoglycans (HSPGs),
which have been shown to be required for maximal hedgehog signaling in
Drosophila, are present in the postnatal EGL and can increase Shh-induced
proliferation of GCPs (Rubin et al., 2002). While none of these factors induces
signiﬁcant proliferation on its own, all may contribute to the proliferation of cells
in the EGL.
Growth factors that act through receptor tyrosine kinases (RTKs) – epider-
mal growth factor (EGF), insulin-like growth factor (IGF-1), and basic ﬁbroblast
growth factor (bFGF) – have been reported to induce GCP proliferation (Gao et
al., 1991; Tao et al., 1996; Ye et al., 1996; Lin and Bulleit, 1997). On their own,
these factors cause a 2- to 4-fold increase in thymidine incorporation in cultured
GCPs. Interestingly, however, they show no evidence of synergy with Shh;
rather, EGF and IGF-1 cause a modest suppression of Shh-induced proliferation
and bFGF reduces the Shh response by 90% (Wechsler-Reya and Scott, 1999).
This suggests that RTK-binding growth factors control proliferation through
mechanisms distinct from the one used by Shh or that they act on distinct subsets
of cerebellar cells. The fact that EGF, IGF-1, and bFGF also have potent effects
on granule cell survival and differentiation (Hatten et al., 1988; Dudek et al.,
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Liu and Kaczmarek, 1998) raises the possibility that these factors may control
aspects of cerebellar development besides proliferation.
III. Granule Cell-cycle Exit and Differentiation
GCPs undergo extensive proliferation during the ﬁrst 2–3 weeks after birth.
But even as proliferation in the EGL reaches its peak, some GCPs are beginning
to exit the cell cycle and differentiate into neurons. One possible explanation for
this cell-cycle exit could be movement of cells away from Shh protein. For
example, Shh might be present only in the outer EGL and, as cells move inward
and away from the mitogenic signal, they might exit the cell cycle. Although this
model has not been completely ruled out, the available evidence argues against
it. Shh is made by Purkinje cells (Wechsler-Reya and Scott, 1999) and the protein
has been detected throughout the EGL (Gritli-Linde et al., 2001; Pons et al.,
2001). Moreover, Shh expression begins during embryonic life and persists into
adulthood (Traiffort et al., 1999). Thus, termination of the proliferative response
probably is not due to reduced exposure to Shh. Rather, it is likely to result from
reduced responsiveness to Shh or conversion of the proliferative response into a
differentiative one.
To date, three signals have been shown to overcome Shh-induced prolifer-
ation: the extracellular matrix molecule vitronectin (VN), the protein kinase A
(PKA) activator forskolin, and bFGF. In contrast to laminin, VN is found
primarily in the inner EGL and granule cells in this region express alpha-v
integrins, which can function as VN receptors (Pons et al., 2001; Wechsler-Reya,
2001). GCPs grown on VN show a 20% reduction in the proliferative response
to Shh and increased -tubulin expression and neurite outgrowth, compared to
cells grown on other substrates. Growth on VN also causes increased phosphor-
ylation of the transcription factor cAMP response element binding protein
(CREB). CREB function appears to be required for VN’s effects on neurite
outgrowth (Pons et al., 2001). These observations suggest that VN may contrib-
ute to granule cell-cycle exit and differentiation.
Forskolin also can inhibit Shh-induced proliferation of GCPs (Wechsler-
Reya and Scott, 1999; Kenney and Rowitch, 2000). This is not surprising, since
PKA activators can inhibit Shh responses in most tissues and in most species (Li
et al., 1995; Hammerschmidt et al., 1996; Ungar and Moon, 1996). Because
forskolin is not a physiologic signal, there must be an endogenous factor that
activates PKA for this to play a role in granule cell development. One good
candidate for a PKA activator is pituitary adenylate cyclase activating polypep-
tide (PACAP) (Sherwood et al., 2000). PACAP is made by Purkinje cells
(Nielsen et al., 1998; Skoglosa et al., 1999) and its receptors are expressed by
GCPs in the outer EGL (Basille et al., 1993). To date, most studies of PACAP
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promotes survival in the presence of various death-inducing stimuli (Vaudry et
al., 1999,2002; Tabuchi et al., 2001). On the other hand, recent studies of
neurons in the embryonic cortex and hindbrain indicate that PACAP can inhibit
proliferation of those cells (Suh et al., 2001; Lelievre et al., 2002). Thus, PACAP
might contribute to cell-cycle exit in the cerebellum as well.
Finally, bFGF is a potent inhibitor of proliferation, reducing the response to
Shh by 90% (Wechsler-Reya and Scott, 1999). bFGF is made by cerebellar
astrocytes and Purkinje cells (Hatten et al., 1988; Matsuda et al., 1994). At least
two receptors capable of binding it (i.e., ﬁbroblast growth factor (FGF)-1 and -4)
are expressed in GCPs in the EGL (el-Husseini et al., 1994; Miyake et al., 1995;
Ozawa et al., 1996; Meiri et al., 1998; Sleptsova-Friedrich et al., 2001). The
observation that bFGF can prevent proliferation is consistent with a variety of
studies demonstrating that it promotes granule cell differentiation and neurite
outgrowth in vitro and in vivo (Williams et al., 1994; Hatten and Heintz, 1995;
Saffell et al., 1997; Liu and Kaczmarek, 1998). However, as mentioned earlier,
bFGF has been reported to induce proliferation of cerebellar cells in vitro and
following subcutaneous injection (Tao et al., 1996; Cheng et al., 2001). In fact,
we have observed that bFGF induces a small increase in thymidine incorporation
in our cultures as well (Wechsler-Reya and Scott, 1999). One possible explana-
tion for these observations is that the proliferative response to bFGF occurs in a
subset of GCPs or in a distinct class of progenitor cells that are present in the
postnatal cerebellum.
As granule cells differentiate, they extend axons and migrate inward, past the
Purkinje cells, to the IGL. Bergmann glia are thought to provide a substrate for
the migration (Edmondson and Hatten, 1987; Hatten, 1990; Komuro and Rakic,
1998) and therefore are a likely source of signals and guidance cues. Autocrine
signaling by brain-derived neurotrophic factor (BDNF) is critical for initiation of
migration from the EGL (Borghesani et al., 2002). Astrotactin, a granule cell
surface molecule with EGF and ﬁbronectin repeats, has been shown to be
important for guiding granule cell migration (Edmondson et al., 1988; Zheng et
al., 1996). Migration also has been shown to be regulated by N-methyl-D-
aspartate (NMDA) receptor activity and intracellular calcium concentration
(Komuro and Rakic, 1993,1996).
IV. Gene Expression Analysis of the Developing Cerebellum
The studies described herein have revealed a number of important factors
that control proliferation and differentiation of granule cells. However, many
important questions remain. For example, the molecular mechanisms by which
Shh and other factors regulate growth of GCPs and the identity of the signals that
control granule cell differentiation and migration in vivo are poorly understood.
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types in the developing cerebellum have not been identiﬁed. One important tool
for identifying such molecules is gene expression analysis. By analyzing changes
in gene expression during the course of cerebellar development, or by isolating
speciﬁc cell types and comparing their gene expression under conditions of
growth and differentiation, it may be possible to identify molecules that are
important in normal growth and differentiation.
One of the ﬁrst efforts at broad-based gene expression analysis in the
cerebellum was carried out by Kuhar et al. (1993). These investigators raised
polyclonal antisera against immature GCP and adsorbed them against PC12 cells
(a cell line resembling peripheral neurons) and adult cerebellum to deplete
non-GCP-speciﬁc antibodies. They then used the antisera to screen a cDNA
expression library derived from GCPs, to identify GCP-speciﬁc genes. Using this
approach, they cloned 39 unique cDNAs, 28 of which represented novel genes
and showed tissue- and stage-speciﬁc expression. The majority were expressed at
high levels early in development (i.e., postnatal days 0–10), then downregulated
by adulthood. Among these genes were at least four distinct expression patterns:
1) those that were localized in the outermost part of the EGL, where GCPs are
proliferating; 2) those expressed in the inner EGL, where cells have exited the
cell cycle and begun to differentiate; 3) genes expressed in the upper IGL, in
postmitotic cells that had not yet completed migration; and 4) genes expressed in
fully differentiated, postmigratory granule cells. These genes (some of which
have now been cloned) (Miwa et al., 1999) not only provide valuable molecular
markers for the stages of granule cell development but also represent a set of
molecules that may play important functional roles in this process.
More-recent studies of gene expression in the cerebellum have taken
advantage of high-throughput approaches using polymerase chain reaction (PCR)
or microarrays. For example, Matoba and colleagues (2000a,b,c) generated
cDNA libraries from cerebella of 4-day-old (P4), 12-day-old (P12), and 6-week-
old (6W) mice and sequenced several thousand clones from each library. They
then chose approximately 400 of these genes (i.e., those with the highest
expression levels) and quantitated their expression levels using a technique
known as adapter-tagged competitive PCR (ATAC-PCR) (Figure 2A). This
involves isolating RNA from each sample (i.e., stage of development), convert-
ing it to cDNA, and then “tagging” one end of that cDNA with an adapter. For
each sample, the cDNA is tagged with a different-sized adapter. The samples
from each stage are mixed into a single tube and ampliﬁed by PCR using an
adapter-speciﬁc primer and a gene-speciﬁc primer. After separation by gel
electrophoresis, products from each sample can be discriminated based on their
size (determined by the unique adapter). The amount of each fragment reﬂects
the amount of original template. Relative expression levels in each sample can be
deduced from their signal intensities.
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sion of genes in the P4, P12, and 6W samples and divided genes into groups
based on expression proﬁles. Although a number of different cell types were
represented, the differences in gene expression proﬁles correlated best with the
development of granule cells, which are by far the most abundant cell type. Early
in development (P4), when GCPs are undergoing rapid proliferation, the most
abundant genes are those encoding ribosomal proteins, cytoskeletal proteins
(e.g., tubulin, actin, thymosin 4), and genes associated with proliferation (e.g.,
cdc2 kinase). Later in development (P12), when granule cells are engaged in
axon extension and synapse formation, genes for mitochondrial activities (cyto-
chrome c oxidase, mitochondrial proton/phosphate symporter), ion channels
(Na/K-ATPase), and markers of differentiated neurons (NeuroD, glutamate
transporter, trkC) are elevated. Expression of many of these genes continues to
increase during development. Finally, at 6 weeks, when differentiation of
cerebellar neurons and glia is complete, elevated expression of synaptic proteins
(e.g., soluble NSF (N-ethylmaleimide-sensitive factor) attachment protein
SNAP25), neurotransmitter receptors (gamma aminobutyric acid receptors,
GABA-Rs), and components of myelin (myelin basic protein and myelin proteo-
lipid protein) are detected.
FIG. 2. Methods of genomic analysis. Procedures for adapter-tagged competitive polymerase
chain reaction (ATAC-PCR), serial analysis of gene expression (SAGE), and Affymetrix GeneChip
(Microarray) analysis are illustrated. [See text for details.]
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include 1800 genes expressed over six different time points in cerebellar
development: 2, 4, 8, and 12 days and 3 and 6 weeks. Their results again were
clustered into 1) genes elevated early in development (e.g., 2, 4, and 8 days); 2)
genes elevated later in development (e.g., 12 days, 3 weeks, 6 weeks); and 3)
genes with complex expression patterns. About 80% of these could be classiﬁed
based on function. The investigators looked for correlations between temporal
expression proﬁles and functional categories and found that genes expressed
early in development were enriched for those encoding cancer-related proteins
(e.g., adenomatous polyposis coli (APC), c-erbA, abl, Krox24/Egr1) and ribo-
somal proteins. Other genes in this group were involved in RNA processing, cell
adhesion/migration (e.g., VN, tenascin, neural cell adhesion molecule (NCAM),
reelin), signaling, and transcription. In contrast, the genes expressed primarily in
late postnatal development included those involved in protein transport, carbo-
hydrate metabolism, “brain-speciﬁc functions,” ion channels and transporters
(ryanodine receptor 2, potassium channels, sodium channels, Na/K ATPases),
lipid metabolism and neurotransmitter receptors (GABA-A receptors, NMDA
receptors, AMPA (alpha-amino-3-hydroxy-5-methylisoxasole proprionic acid)
receptors) and synapse components, and genes associated with mature oligoden-
drocytes (myelin basic protein, myelin proteolipid protein). Having found a
number of known genes with documented functions in cerebellar development,
the authors suggest that this approach may be used to identify novel genes that
regulate granule cell growth and differentiation.
Gene expression in the postnatal cerebellum has also been studied by
Kaltschmidt and Kaltschmidt (2001). These investigators initially were interested
in the role of the transcription factor nuclear factor kappa B (NF-B) in neuronal
survival. They found that NF- is expressed at high levels in the EGL before
P7 and declines between P7 and P12. To identify signals that might account for
this change in expression, the researchers used cDNA arrays to compare gene
expression in P4 vs. P12 cerebellum. The arrays they used were commercial
nylon membranes (macroarrays) spotted with 588 known cDNAs. mRNA from
each developmental stage was labeled with
32P and hybridized to a ﬁlter. Then,
the level of hybridization was quantitated and compared using a phosphorimager.
While most of the genes did not change, a small group ( 40/588) was
developmentally regulated; most of these increased between P4 and P12 but
some decreased. Changes in expression were found among genes associated with
proliferation and differentiation (c-myc, cyclin D3, cdc-like kinase 2, Id3),
apoptosis and DNA repair (growth arrest and DNA damage (GADD45), topo-
isomerase II, TNF receptor-associated death domain (TRADD)), cell-signaling
molecules (extracellular signal-regulated kinase (ERK)1, ERK3, jun kinase
(JNK)3, mitogen-activated protein kinase (MAPK)2), cell adhesion (contactin 1,
integrin 4, N-cadherin, lymphocyte function-associated antigen 1 (LFA-1)), and
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receptor (FGFR)1, transforming growth factor (TGF)-2, macrophage colony-
stimulating factor (MCSF), fms-like tyrosine kinase (FLT-3) ligand).
The most highly induced gene during this period of development was the
cytokine, TGF-2. The authors conﬁrmed expression of TGF-2 in the EGL by
in situ hybridization (ISH) and antibody staining and showed that expression
levels increased signiﬁcantly from P4 to P12. To test the functional effects of
TGF-2, they added the factor to granule cells in culture and showed that it
causes a rapid decrease in expression of the transcription factor, NF-B. Since
TGF-2 can promote granule cell apoptosis (de Luca et al., 1996) and NF-B
can promote survival (Koulich et al., 2001; Piccioli et al., 2001), the authors
suggest that increased expression of TGF-2 may play a role in the apoptosis that
occurs during normal granule cell development in vivo (Wood et al., 1993).
Among the other genes whose expression increased from P4 to P12 were a
number of elements of the FGF signaling pathway, including FGF receptor 1,
MAPK2, ERK1, ERK3, and CREB2. As previously discussed, FGF signaling
can promote granule cell-cycle exit and differentiation in vitro. The fact that
multiple components of the FGF signaling pathway are coordinately regulated
during a period of granule cell differentiation is consistent with the possibility
that it plays this role in vivo as well. However, further studies of the effects of
FGF signaling on granule cell development are necessary to validate this notion.
A more-comprehensive study of gene expression in the developing cerebel-
lum was carried out by Zhao et al. (2002). These investigators initially examined
gene induction in GCPs following Shh treatment, to identify target genes induced
by this stimulus. They isolated cells from P4–5 cerebellum and treated them with
Shh protein for 3 or 24 hours, then harvested RNA for microarray analysis using
Affymetrix GeneChips (Figure 2B). These arrays consist of thousands of short
oligonucleotides (25-mers) conjugated to a solid matrix. Each gene is represented
by 10–15 oligonucleotides that match the coding sequence and a corresponding
set of oligonucleotides that contain a one-base mismatch; the latter serve as
controls for the speciﬁcity of hybridization. To analyze gene expression in a
sample, RNA is isolated, converted to cDNA, and transcribed to generate
biotin-labeled cRNA. This cRNA is hybridized to the Chip, incubated with a
streptavidin-conjugated ﬂuorescent dye, and scanned to detect the amount of
ﬂuorescence for each oligonucleotide. Analytical software is used to determine
the expression levels of each gene and to compare expression between samples.
In their experiments, Zhao and colleagues found that  4% of the 13,000
genes on their microarrays were upregulated by Shh. Among these genes,  90%
were involved in cell-cycle regulation (e.g., cyclins D1, B1, B2, A2, proliferating
cell nuclear antigen (PCNA), E2F1, Ki67, cdc20). Other genes overexpressed in
Shh-treated cells included transcription factors (Pax2, Math1, Gli2, N-myc) and
genes involved in DNA replication and ribosome assembly. For comparison, the
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Shh, to identify genes that are induced by Shh in postmitotic granule cells.
Although Shh did induce gene expression in these cells, the targets were largely
distinct from those induced in GCPs.
To test whether the targets of Shh in proliferating GCPs were expressed in
these cells in vivo, Zhao et al. examined expression of a number of genes by ISH.
These studies revealed that 10/12 of the genes analyzed were expressed in EGL
at postnatal day 1–7 and were downregulated by postnatal day 15. Based on these
ﬁndings, the authors proposed the concept of a temporal gene regulation proﬁle
(TRP) for the EGL: a set of genes that is temporally regulated in a pattern
consistent with expression and function in proliferating GCPs in the EGL. In
other words, genes whose expression was high from P1–P7 and low after P15
were likely to represent genes expressed in the EGL. If this concept could be
validated, EGL-speciﬁc genes could be identiﬁed based solely on their expres-
sion proﬁle during postnatal cerebellar development.
To test this hypothesis, the authors performed microarray analysis on whole
cerebellum from P1–P30. In an initial test, they found that 10/12 genes that were
known to be expressed in the EGL were expressed at high levels in P3–7 and
downregulated from P15–30. To further validate this, they used microarray data
to generate a list of genes whose developmental expression pattern ﬁt that of the
TRP-EGL, then examined their localization by ISH. The TRP-EGL proﬁle
correctly predicted EGL expression for more than 80% of the genes. These
studies suggest that one can prospectively identify genes expressed in GCPs
based on temporal changes in expression within the whole cerebellum.
These studies demonstrate that gene expression analysis can be a powerful
tool for studying development and can provide valuable information about the
genes that regulate cell growth and differentiation in a tissue. But when studying
changes in gene expression during development – especially within an intact
tissue – it is important to keep several issues in mind. First, changes in gene
expression in the tissue may reﬂect changes in expression levels within a given
cell type or changes in abundance of that cell type within the tissue. In fact, for
much of cerebellar development, the abundance of granule cells tends to swamp
out gene expression from most other cell types, including Purkinje cells,
astrocytes, oligodendrocytes, and other interneurons. In order to learn about the
genes that control development of these cells, it may be necessary to isolate them
using laser capture microdissection (LCM) (Vincent et al., 2002) or antibody-
based puriﬁcation methods such as panning or ﬂuorescence-activated cell sorting
(Trotter and Schachner, 1989; Baptista et al., 1994; Catapano et al., 2001;
Sawamoto et al., 2001). Alternatively, studies of mutant mice that have defects
in particular cell types (Mullen et al., 1997) may shed light on the gene
expression patterns important for particular aspects of cerebellar development.
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expression analysis is only a ﬁrst step towards understanding the molecular
mechanisms of development. Once a proﬁle of gene expression is identiﬁed,
additional criteria must be used to narrow down the list of genes to a manageable
number for further study. For example, one might focus on transcription factors
or secreted proteins or genes that are likely to control cell adhesion or movement.
Alternatively, it might be useful to perform additional screens to determine which
of the expressed genes is dysregulated in a particular mutant mouse. Given a
short list of genes, functional analysis — both in vitro and in vivo — will be
necessary to understand how these genes contribute to a particular developmental
process.
In addition to their importance in understanding cerebellar development,
studies of gene expression in the normal cerebellum may have important
implications for understanding the etiology of cerebellar tumors. For example, a
number of genes expressed in the EGL and in GCPs stimulated with Shh (e.g.,
cyclin D1, N-myc, gli2) also have been shown to be expressed at high levels in
some types of medulloblastoma (Pomeroy et al., 2002). This raises the possibility
that other genes involved in regulating cerebellar growth, differentiation, and
apoptosis might play a role in tumorigenesis.
V. Medulloblastoma
Medulloblastoma is a highly malignant tumor of the cerebellum. It occurs
most commonly in children between 5 and 10 years of age and accounts for
20–30% of all pediatric brain tumors (Schiffer, 1997; Zakhary et al., 2001). The
disease usually is treated with a combination of surgery, radiation, and chemo-
therapy. While these approaches often are effective at shrinking the primary
tumor, recurrence and metastasis are common and only 50% of patients survive
for 5 years after diagnosis. Moreover, aggressive treatment of children with
radiation and chemotherapy has been found to impair intellectual and physical
development (Zakhary et al., 2001). New approaches to the diagnosis and
treatment of medulloblastoma clearly are necessary and are most likely to come
from a deeper understanding of the cellular and molecular basis of this disease.
Histologically, medulloblastoma often is divided into two major subtypes:
classic and desmoplastic (Zakhary et al., 2001; Pomeroy et al., 2002). Classic
medulloblastoma consists of small, round, densely packed cells that show little
evidence of morphologic differentiation. Desmoplastic (or nodular) medulloblas-
tomas contain regions of densely packed cells with extensive reticulin ﬁbers
surrounding “pale islands” of cells that are much less dense. The majority of
medulloblastomas have the classic morphology; only 20–25% of tumors are
considered desmoplastic. The cell of origin is not clear for either subtype but
some studies suggest that desmoplastic tumors may arise from GCPs in the EGL,
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ventricles and normally give rise to Purkinje cells, cerebellar interneurons, and
glia (Katsetos and Burger, 1994; Buhren et al., 2000).
An important step in understanding the molecular basis of medulloblastoma
came from studies of the Sonic hedgehog-Patched signaling pathway (Ingham
and McMahon, 2001). As discussed, Shh is a secreted molecule that plays a
critical role in embryonic development and is a major regulator of proliferation
in the developing cerebellum (Dahmane and Ruiz-i-Altaba, 1999; Wechsler-
Reya and Scott, 1999). Patched (Ptc) is a transmembrane protein that functions
as both a Shh receptor and an antagonist of Shh signaling. Several lines of
evidence indicate that Shh-Ptc signaling is involved in medulloblastoma. First,
the human patched gene has been identiﬁed as the locus mutated in Gorlin’s
syndrome, a disease characterized by skin tumors, craniofacial defects, and
increased incidence of medulloblastoma (Hahn et al., 1996; Johnson et al., 1996).
Second, many sporadic medulloblastomas (especially those of the desmoplastic
type) have been found to harbor mutations in patched and other elements of the
Shh pathway (Pietsch et al., 1997; Raffel et al., 1997; Lam et al., 1999; Taylor
et al., 2002). Finally, mice in which the patched gene has been disrupted develop
tumors that resemble medulloblastoma (Goodrich et al., 1997; Hahn et al., 2000).
Among the other genes associated with human medulloblastoma are com-
ponents of the Wnt signaling pathway. Patients with Turcot’s syndrome – which
results from mutations in the APC gene – have a high incidence of colorectal
cancers and brain tumors, especially medulloblastoma (Hamilton et al., 1995).
About 4% of sporadic medulloblastomas have been shown to contain APC
mutations (Huang et al., 2000). In addition, 8–15% have been reported to harbor
activating mutations in -catenin and 12% have mutations in Axin, a negative
regulator of Wnt signaling (Zurawel et al., 1998; Eberhart et al., 2000; Huang et
al., 2000; Dahmen et al., 2001). These ﬁndings suggest that a subset of
medulloblastomas may result from activation of the Wnt pathway. Medulloblas-
tomas also have been found to exhibit overexpression of the transcription factors
N-myc, c-myc, pax5, and zic and of the receptor tyrosine kinase ErbB2 (Garson
et al., 1989; Bigner et al., 1990; Gilbertson et al., 1995; Kozmik et al., 1995;
Yokota et al., 1996). Whether these genes contribute to the development or
progression of medulloblastoma, or whether they simply represent markers of the
transformed cell type, remains to be determined. Animals in which these genes
are misexpressed will provide valuable insight into their role in the etiology of
medulloblastoma.
One of the most important genes involved in medulloblastoma has yet to be
identiﬁed. Of human medulloblastomas, 30–50% have a deletion or rearrange-
ment of part of chromosome 17 (Cogen and McDonald, 1996; Bigner et al.,
1997; Burnett et al., 1997). In most cases, the short arm (17p) is lost and
head-to-head apposition of the long arms (17q) occurs, which is referred to as
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leukemias, lymphomas, and cancers of the stomach, colon, and cervix. The loss
of 17p in a number of types of cancer suggests that at least one potent tumor
suppressor gene is located there. Fine mapping of deletions from different tumors
has narrowed the region of interest considerably. Most investigators now believe
that the putative tumor suppressor is located at 17p13.3, a region of  20 known
genes, including those encoding the lissencephaly-associated protein Lis1, the
breakpoint cluster region (BCR)-related gene ABR, the Max-binding protein Mnt,
and the transcription factor hypermethylated in cancer-1 (Hic1) (Koch et al.,
1996; Steichen-Gersdorf et al., 1997; Sommer et al., 1999; Hoff et al., 2000;
Rood et al., 2002). Although none of these genes has been linked deﬁnitively to
the etiology of medulloblastoma, there is no question that when the chromosome
17 tumor suppressor is identiﬁed, it will provide important insight into the basis
of cerebellar tumors as well as into normal cerebellar development.
VI. Gene Expression Proﬁling of Medulloblastoma
In an effort to identify important genes involved in medulloblastoma, a
number of investigators have begun to carry out gene expression analysis on
primary tumor samples. One of the ﬁrst efforts was performed by Michiels and
colleagues (1999), who analyzed gene expression in a human medulloblastoma
sample using serial analysis of gene expression (SAGE) (Figure 2C). SAGE is
based on the principle that a sequence of 9–10 nucleotides can be used to identify
a transcript, if the position of these nucleotides within the transcript is known. A
biotinylated oligo(dT) primer is used to synthesize cDNA from mRNA and, after
digestion with a restriction enzyme, fragments are isolated from the 3 end of
each transcript. Fragments are ligated to linkers, then cleaved with a restriction
enzyme to release a short sequence (i.e., 9–10 bp) from a deﬁned region of the
original cDNA (a “tag”). Tags are ligated together to form long concatamers,
which are cloned and sequenced. Using this approach, one sequencing reaction
can yield information about the number and distribution of many different tags.
With the appropriate software, the sequence and position of the tag can be used
to identify the gene from which each tag was derived. Moreover, the number of
times each tag appears in the sequencing reaction is proportional to the abun-
dance of that gene in the original sample. In this manner, SAGE gives a
quantitative representation of gene expression in a sample.
For their study, Michiels and colleagues used SAGE to compare genes
expressed in medulloblastoma to those expressed in 24.5-week fetal brain. They
sequenced 10,000 tags from each sample and found about 6000 unique genes in
each case. Among the most highly expressed genes in both samples were those
encoding ribosomal proteins, consistent with the idea that both of these tissues
contain highly proliferative (and protein-synthesizing) cells. Comparing the
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whose expression differed signiﬁcantly. About half of these were known genes,
including the transcription factors Zic1, Otx2, and Sox4; the secretory protein
secretogranin; vascular endothelial growth factor (VEGF); and PCNA. Expres-
sion of Zic1 and Otx2 was examined by Northern blotting and found to be
elevated in a number of independent medulloblastoma samples. The fact that
both of these genes are expressed in the EGL lends support to the notion that at
least some cases of medulloblastoma arise from GCPs.
A particularly elegant study of medulloblastoma gene expression was carried
out by Pomeroy and colleagues (2002), who used Affymetrix GeneChips to
compare medulloblastoma to other types of brain tumors. Since pathologists
commonly have grouped medulloblastoma with primitive neuroectodermal tu-
mors (PNETs) from other parts of the brain, the investigators were particularly
interested in determining how similar these tumor types were. Studying the gene
expression proﬁles of 42 brain tumors — including medulloblastoma, malignant
glioma, atypical teratoid/rhabdoid tumors, and PNETs — they found that each of
these tumor types was molecularly distinct. For example, gliomas expressed
markers of astrocytic and oligodendrocytic cells (phosphoprotein-enriched in
astrocytes-15 kDa (PEA15), SRY-related box2 (SOX2), peripheral myelin pro-
tein 2 (PMP2), Olig-2, S100, glial ﬁbrillary acidic protein (GFAP)), whereas
medulloblastomas expressed genes characteristic of cerebellar granule cells (e.g.,
Zic, neurological stem cell leukemia transcription factor (NSCL1)). Interestingly,
although medulloblastoma and PNET look similar morphologically, they are
molecularly distinct, with PNETs lacking Zic and NSCL1 and expressing high
levels of nicotinic cholinergic receptor subunits and DNA polymerase delta 1
(POLD1).
Pomeroy et al. next addressed whether the two major subtypes of medullo-
blastoma described by pathologists – classic and desmoplastic – had distinct gene
expression proﬁles. Consistent with the observation that desmoplastic tumors
have a high incidence of Shh pathway mutations (Pietsch et al., 1997; Taylor et
al., 2002), the researchers showed that desmoplastic tumors express high levels
of Patched, Gli1, IGF-2, and N-myc, which have been identiﬁed as transcrip-
tional targets of the Shh pathway (Goodrich et al., 1996; Hahn et al., 2000;
Wetmore et al., 2000; Zhao et al., 2002). In addition, desmoplastic tumors
express high levels of the antiapoptotic protein Bcl2 and ribosomal proteins,
similar to those seen in normal EGL GCPs. In contrast, classic tumors show
elevated levels of TGF3 and elements of its signaling pathway (Smad2, Smad5)
and increased expression of the transcription factors distal-less homeobox gene
7 (DLX7), LIM-homeobox domain protein-2 (LH-2), and NeuroD3. These data
clearly indicate that desmoplastic and classic medulloblastoma are not only
histologically distinct but also have different gene expression proﬁles.
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bilities. First, they may reﬂect differences in the cell type of origin or cellular
composition of the tumors. For example, desmoplastic tumors may arise from
GCPs, while classic tumors may arise from multipotent precursors in the
ventricular zone. On the other hand, these tumors could arise from the same cell
type. Differentially expressed genes might reﬂect activation of distinct signaling
pathways that contribute to the etiology of tumor formation. Determining the
functional signiﬁcance of each of these genes is an important task for future
study.
Independent of the role of these genes in the etiology of tumor formation,
they may be signiﬁcant as indicators of tumor prognosis and responsiveness to
therapy. This is particularly important in medulloblastoma, since a signiﬁcant
percentage of patients may be cured by chemotherapy and radiation, while others
are resistant and succumb to the disease. To address this possibility, Pomeroy et
al. analyzed tumors from patients who had been treated and followed to
determine the outcome of treatment. The data then were analyzed using a
“supervised learning” scheme to determine which genes were best correlated
with long-term survival. Among the best predictors of survival were genes
associated with cerebellar differentiation (the vesicle coat protein -NAP, the
transcription factor NSCL1, the neurotrophin receptor TrkC, and sodium chan-
nels), and genes encoding extracellular matrix proteins (procollagen lysyl hy-
droxylase (PLOD), collagen type V1, elastin). On the other hand, poor prog-
nosis was associated with increased expression of ribosomal proteins, the
proliferation-associated genes B-myb and E2F5, and metabolic genes such as
lactate dehydrogenase and cytochrome C oxidase. The multidrug resistance gene
sorcin also was associated with poor outcome. Exactly how these genes might
contribute to tumor progression (or resistance to therapy) remains to be deter-
mined. However, as a diagnostic tool, the ability to predict tumor outcome based
on gene expression proﬁle is likely to be extremely valuable.
A study of gene expression in metastatic medulloblastoma by MacDonald et
al. (2001) may offer similar advantages. About one third of patients with
medulloblastoma have metastatic disease at time of diagnosis and these patients
are known to have a particularly poor outcome. In fact, disseminated disease is
among the most powerful predictors of poor survival in medulloblastoma
patients. To ﬁnd molecular markers of metastatic medulloblastoma, these re-
searchers used Affymetrix GeneChips to analyze gene expression in 10 meta-
static (M) and 13 nonmetastatic (M0) tumors. Of the 1992 genes on these
arrays, 59 (3%) showed signiﬁcantly increased expression in M tumors and 26
(1%) showed signiﬁcantly decreased expression. One prominent category of
regulated genes included cell-surface and secreted proteins involved in adhesion
and angiogenesis: -catenin; - and -integrins; secreted protein, acidic and rich
in cysteine (SPARC); tissue inhibitor of matrix metalloproteinases (TIMP1); and
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MAP kinase signaling (platelet-derived growth factor receptor alpha (PDGFRA),
FGF receptor 2, the adapter protein Src homology/collagen-related-1 (SHC1), the
guanine nucleotide exchange factor (GEF2), rac-kinase , protein kinase C-II,
JNK1) also were differentially expressed in metastatic vs. nonmetastatic tumors.
Finally, metastatic tumors showed altered expression of transcription factors,
including Hox A4 and A7 (which were overexpressed) and Nur77 and c-myb
(which were expressed at lower levels). No differences were seen in expression
of N-myc, patched, or ErbB2, which had previously been shown to be associated
with medulloblastoma.
MacDonald and colleagues went on to develop an algorithm to predict
whether a tumor was metastatic or nonmetastatic, based on its gene expression
proﬁle. This algorithm was able to predict tumor class with 72% accuracy and
correctly categorized four new tumors. It predicted nonmetastatic tumors more
accurately than metastatic ones, possibly because metastatic tumors are more
heterogeneous with respect to cell type or gene expression proﬁle. In addition to
primary tumors, the authors analyzed the gene expression proﬁle of several
medulloblastoma cell lines. Although some of these lines could not be catego-
rized, Daoy cells, a commonly used medulloblastoma cell line, clearly were
categorized as metastatic.
The authors were particularly interested in elevated expression of PDGFRA
and elements of the Ras-MAP kinase pathway in metastatic tumors, since PDGF
has been shown to regulate angiogenesis, adhesion, and metastasis in other
systems. They conﬁrmed expression of PDGFRA protein in a panel of indepen-
dent metastatic tumors as well as in Daoy cells. They then showed that soluble
PDGFA causes activation of the Ras-MAPK pathway (including phosphorylation
of MEK1, MEK2, and p42/p44 MAPK) in Daoy cells and enhances migration of
these cells in culture. These effects could be prevented by PDGFRA-blocking
antibodies and by MEK inhibitors. These ﬁndings suggested that inhibitors of the
PDGFR or the Ras pathway could be used to treat metastatic medulloblastoma.
Together, these studies clearly demonstrate that gene expression proﬁles can
be used to categorize tumors and to learn about their etiology. They also can be
employed as diagnostic tools to predict prognosis and to choose appropriate
treatment strategies. Finally, by highlighting signaling pathways that are dys-
regulated in tumors, gene expression information may yield new molecular
targets or new approaches to treating tumors.
As with studies of normal development, there are a number of caveats to
studying gene expression in intact tumors. First, tumors are heterogeneous and
may contain a variety of cell types, including proliferating tumor cells, tumor
cells that have undergone differentiation or apoptosis, blood and endothelial
cells, and reactive astrocytes. Again, isolation of these cell types may yield
important information about the molecular mechanisms of tumorigenesis. In
242 ROBERT J. WECHSLER-REYAaddition, it is important to note that differences in gene expression between
normal and tumor cells (or between different types of tumors) may reﬂect
differences in the cell types represented, in genes that are important for the
etiology of the tumor, or genes that are expressed as a consequence of tumor
growth. Distinguishing between these possibilities may not be important if the
goal is to identify prognostic or diagnostic markers but will be critical for
understanding the underlying mechanisms of tumorigenesis.
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